MDT vs PBYI · P/E 21, rev $36.36B vs P/E 4.3, rev $56.5M
Medtronic PLC (MDT) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the MDT and PBYI stock pages for the full models.
Not investment advice.